Nephros, Inc.
(NASDAQ : NEPH)

( )
NEPH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.62%612.081.0%$684.66m
DHRDanaher Corp. -0.63%305.010.7%$671.48m
ABTAbbott Laboratories -0.38%127.640.8%$669.83m
MDTMedtronic Plc -1.23%122.520.6%$559.02m
ISRGIntuitive Surgical, Inc. 0.08%348.980.8%$500.82m
ALGNAlign Technology, Inc. 1.87%604.396.3%$411.07m
BDXBecton, Dickinson & Co. -0.60%244.871.0%$294.44m
SYKStryker Corp. -1.76%268.371.3%$267.85m
EWEdwards Lifesciences Corp. -0.85%116.000.4%$266.69m
DXCMDexCom, Inc. -1.26%558.547.8%$257.45m
BSXBoston Scientific Corp. -1.29%43.751.0%$243.78m
AAgilent Technologies, Inc. -1.90%155.191.6%$210.28m
IDXXIDEXX Laboratories, Inc. -1.76%640.503.8%$198.24m
BAXBaxter International, Inc. 0.26%82.001.8%$186.48m
INMDInMode Ltd. -5.34%82.840.0%$182.26m

Company Profile

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.